Invention Grant
- Patent Title: Compositions and methods for selective elimination and replacement of hematopoietic stem cells
-
Application No.: US16493853Application Date: 2018-03-13
-
Publication No.: US11744861B2Publication Date: 2023-09-05
- Inventor: Eric M. Ostertag , Devon Shedlock , Julian David Down
- Applicant: Poseida Therapeutics, Inc.
- Applicant Address: US CA San Diego
- Assignee: Poseida Therapeutics, Inc.
- Current Assignee: Poseida Therapeutics, Inc.
- Current Assignee Address: US CA San Diego
- Agency: Cooley LLP
- Agent Ivor R. Elrifi; Matthew Pavao
- International Application: PCT/US2018/022169 2018.03.13
- International Announcement: WO2018/169948A 2018.09.20
- Date entered country: 2019-09-13
- Main IPC: A61K35/17
- IPC: A61K35/17 ; A61K9/00 ; A61K31/664 ; A61K31/7076 ; A61K35/28 ; A61K38/17 ; A61K38/19 ; A61K38/48 ; A61K38/52 ; A61K39/39 ; A61K39/395 ; A61K45/06 ; C12N5/0783 ; C12N9/12 ; C12N9/22 ; C12N15/11

Abstract:
Disclosed are methods of eliminating at least on target cell in a subject, comprising administering to the subject an effective amount of a composition comprising a plurality of immune cells, wherein each immune cell of the plurality expresses one or more chimeric ligand receptor(s) (CLR(s)) that each specifically bind to a target ligand on the at least one target cell, wherein specifically binding of the one or more CLR(s) to the target activates the immune cell, and wherein the activated immune cell induces death of the target cell. Exemplary target cells include, but are not limited to, hematopoietic stem cells (HSCs).
Public/Granted literature
- US20200078402A1 COMPOSITIONS AND METHODS FOR SELECTIVE ELIMINATION AND REPLACEMENT OF HEMATOPOIETIC STEM CELLS Public/Granted day:2020-03-12
Information query
IPC分类: